180 related articles for article (PubMed ID: 33517446)
1. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
[TBL] [Abstract][Full Text] [Related]
2. Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease.
McCarthy GM; Blasio A; Donovan OG; Schaller LB; Bock-Hughes A; Magraner JM; Suh JH; Tattersfield CF; Stillman IE; Shah SS; Zsengeller ZK; Subramanian B; Friedman DJ; Pollak MR
Dis Model Mech; 2021 Aug; 14(8):. PubMed ID: 34350953
[TBL] [Abstract][Full Text] [Related]
3. Early recurrence of focal segmental glomerulosclerosis in a kidney transplant recipient with
Acharya R; Upadhyay K
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37258049
[No Abstract] [Full Text] [Related]
4. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.
Gupta Y; Friedman DJ; McNulty MT; Khan A; Lane B; Wang C; Ke J; Jin G; Wooden B; Knob AL; Lim TY; Appel GB; Huggins K; Liu L; Mitrotti A; Stangl MC; Bomback A; Westland R; Bodria M; Marasa M; Shang N; Cohen DJ; Crew RJ; Morello W; Canetta P; Radhakrishnan J; Martino J; Liu Q; Chung WK; Espinoza A; Luo Y; Wei WQ; Feng Q; Weng C; Fang Y; Kullo IJ; Naderian M; Limdi N; Irvin MR; Tiwari H; Mohan S; Rao M; Dube GK; Chaudhary NS; Gutiérrez OM; Judd SE; Cushman M; Lange LA; Lange EM; Bivona DL; Verbitsky M; Winkler CA; Kopp JB; Santoriello D; Batal I; Pinheiro SVB; Oliveira EA; Simoes E Silva AC; Pisani I; Fiaccadori E; Lin F; Gesualdo L; Amoroso A; Ghiggeri GM; D'Agati VD; Magistroni R; Kenny EE; Loos RJF; Montini G; Hildebrandt F; Paul DS; Petrovski S; Goldstein DB; Kretzler M; Gbadegesin R; Gharavi AG; Kiryluk K; Sampson MG; Pollak MR; Sanna-Cherchi S
Nat Commun; 2023 Nov; 14(1):7836. PubMed ID: 38036523
[TBL] [Abstract][Full Text] [Related]
5. Kidney Disease-Associated
Datta S; Kataria R; Zhang JY; Moore S; Petitpas K; Mohamed A; Zahler N; Pollak MR; Olabisi OA
J Am Soc Nephrol; 2020 Sep; 31(9):2083-2096. PubMed ID: 32675303
[TBL] [Abstract][Full Text] [Related]
6. Obesity-related glomerulopathy in the presence of APOL1 risk alleles.
Valdez Imbert R; Hti Lar Seng NS; Stokes MB; Jim B
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35985743
[TBL] [Abstract][Full Text] [Related]
7. APOL1-G2 accelerates nephrocyte cell death by inhibiting the autophagy pathway.
Zhu JY; Lee JG; Fu Y; van de Leemput J; Ray PE; Han Z
Dis Model Mech; 2023 Dec; 16(12):. PubMed ID: 37969018
[TBL] [Abstract][Full Text] [Related]
8. APOL1 kidney risk variants in glomerular diseases modeled in transgenic mice.
Yoshida T; Latt KZ; Santo BA; Shrivastav S; Zhao Y; Fenaroli P; Chung JY; Hewitt SM; Tutino VM; Sarder P; Rosenberg AZ; Winkler CA; Kopp JB
bioRxiv; 2023 Mar; ():. PubMed ID: 37090576
[No Abstract] [Full Text] [Related]
9. Nonpodocyte Roles of APOL1 Variants: An Evolving Paradigm.
Pell J; Nagata S; Menon MC
Kidney360; 2023 Sep; 4(9):e1325-e1331. PubMed ID: 37461136
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein L1 and mechanisms of kidney disease susceptibility.
Bruggeman LA; Sedor JR; O'Toole JF
Curr Opin Nephrol Hypertens; 2021 May; 30(3):317-323. PubMed ID: 33767059
[TBL] [Abstract][Full Text] [Related]
11.
Ma L; Palmer ND; Choi YA; Murea M; Snipes JA; Parks JS; Langefeld CD; Freedman BI
Kidney360; 2020 Dec; 1(12):1353-1362. PubMed ID: 35372896
[TBL] [Abstract][Full Text] [Related]
12. APOL1 channel blocker reduces proteinuria in FSGS.
Olabisi OA
Kidney Int; 2023 Aug; 104(2):228-230. PubMed ID: 37224918
[No Abstract] [Full Text] [Related]
13. APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease.
Datta S; Antonio BM; Zahler NH; Theile JW; Krafte D; Zhang H; Rosenberg PB; Chaves AB; Muoio DM; Zhang G; Silas D; Li G; Soldano K; Nystrom S; Ferreira D; Miller SE; Bain JR; Muehlbauer MJ; Ilkayeva O; Becker TC; Hohmeier HE; Newgard CB; Olabisi OA
J Clin Invest; 2024 Jan; 134(5):. PubMed ID: 38227370
[TBL] [Abstract][Full Text] [Related]
14. Single-Cell Transcriptional Signatures of Glomerular Disease in Transgenic Mice with APOL1 Variants.
Yoshida T; Latt KZ; Santo BA; Shrivastav S; Zhao Y; Fenaroli P; Chung JY; Hewitt SM; Tutino VM; Sarder P; Rosenberg AZ; Winkler CA; Kopp JB
J Am Soc Nephrol; 2024 May; ():. PubMed ID: 38709562
[TBL] [Abstract][Full Text] [Related]
15. Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.
Kawakami T; Gomez IG; Ren S; Hudkins K; Roach A; Alpers CE; Shankland SJ; D'Agati VD; Duffield JS
J Am Soc Nephrol; 2015 May; 26(5):1040-52. PubMed ID: 25406339
[TBL] [Abstract][Full Text] [Related]
16. Strong protective effect of the
Gupta Y; Friedman DJ; McNulty M; Khan A; Lane B; Wang C; Ke J; Jin G; Wooden B; Knob AL; Lim TY; Appel GB; Huggins K; Liu L; Mitrotti A; Stangl MC; Bomback A; Westland R; Bodria M; Marasa M; Shang N; Cohen DJ; Crew RJ; Morello W; Canetta P; Radhakrishnan J; Martino J; Liu Q; Chung WK; Espinoza A; Luo Y; Wei WQ; Feng Q; Weng C; Fang Y; Kullo IJ; Naderian M; Limdi N; Irvin MR; Tiwari H; Mohan S; Rao M; Dube G; Chaudhary NS; Gutiérrez OM; Judd SE; Cushman M; Lange LA; Lange EM; Bivona DL; Verbitsky M; Winkler CA; Kopp JB; Santoriello D; Batal I; Brant Pinheiro SV; Araújo Oliveira E; E Silva ACS; Pisani I; Fiaccadori E; Lin F; Gesualdo L; Amoroso A; Ghiggeri GM; D'Agati VD; Magistroni R; Kenny EE; Loos RJF; Montini G; Hildebrandt F; Paul DS; Petrovski S; Goldstein DB; Kretzler M; Gbadegesin R; Gharavi AG; Kiryluk K; Sampson MG; Pollak MR; Sanna-Cherchi S
medRxiv; 2023 Aug; ():. PubMed ID: 37577628
[TBL] [Abstract][Full Text] [Related]
17. The complicated role of mitochondria in the podocyte.
Gujarati NA; Vasquez JM; Bogenhagen DF; Mallipattu SK
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F955-F965. PubMed ID: 33073585
[TBL] [Abstract][Full Text] [Related]
18. Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu.
Mishra A; Ayasolla K; Kumar V; Lan X; Vashistha H; Aslam R; Hussain A; Chowdhary S; Marashi Shoshtari S; Paliwal N; Popik W; Saleem MA; Malhotra A; Meggs LG; Skorecki K; Singhal PC
Am J Physiol Renal Physiol; 2018 May; 314(5):F832-F843. PubMed ID: 29357419
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis.
Li Y; Fan J; Zhu W; Niu Y; Wu M; Zhang A
Kidney Dis (Basel); 2023 Aug; 9(4):254-264. PubMed ID: 37900001
[TBL] [Abstract][Full Text] [Related]
20. Blocking the 5' splice site of exon 4 by a morpholino oligomer triggers APOL1 protein isoform switch.
Cheatham AM; Davis SE; Khatua AK; Popik W
Sci Rep; 2018 Jun; 8(1):8739. PubMed ID: 29880816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
